Japanese Pharma Co. Drops IP Amid Row With Novo Nordisk
Novo Nordisk has obtained an inadvertent win against a rival's patent for a method of modifying antibodies in the blood, after the Japanese pharmaceutical company told European appellate officials that it...To view the full article, register now.
Already a subscriber? Click here to view full article